Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 11, 2025 • 4:01 PM ET

Date/Time Source News Release
05/28/2025 04:01 PM EDT GlobeNewswire Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
05/15/2025 04:01 PM EDT GlobeNewswire Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
04/28/2025 04:30 PM EDT GlobeNewswire Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
04/15/2025 04:01 PM EDT GlobeNewswire Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
03/19/2025 04:01 PM EDT GlobeNewswire Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
01/21/2025 07:00 AM EST GlobeNewswire Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion Leaders
11/26/2024 07:00 AM EST GlobeNewswire Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
11/05/2024 09:05 AM EST GlobeNewswire Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
11/05/2024 09:00 AM EST GlobeNewswire Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
11/04/2024 07:00 AM EST GlobeNewswire Century Therapeutics to Present at Guggenheim's Inaugural Healthcare Innovation Conference
Page

Additional News

As of July 11, 2025 • 4:01 PM ET

Date/Time Source News Release
07/10/2025 05:14 PM EDT SeekingAlpha Century Therapeutics files $200M mixed shelf offering
06/25/2025 08:50 AM EDT Zacks Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum
06/06/2025 08:50 AM EDT Zacks Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
05/16/2025 04:45 AM EDT SeekingAlpha Century Therapeutics GAAP EPS of $0.89, revenue of $109.16M
05/15/2025 08:15 PM EDT Zacks Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates
05/15/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 15th, 2025
05/15/2025 05:30 AM EDT US Earnings Reports Expected earnings - Century Therapeutics Inc.
05/14/2025 06:48 PM EDT KlickAnalytics IPSC - Historical Price Movements Surrounding Earnings
05/14/2025 06:43 PM EDT KlickAnalytics IPSC - Historical Earnings Price Analysis
05/14/2025 05:10 PM EDT Zacks Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.